Theravance Biopharma, Inc. (TBPH) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $227K. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | −$226,793 | 13,314 | −6% | Yes | |
|
|
||||||
| Aug. 24, 2026 filed Aug. 20, 2026 | Winningham Rick E CHIEF EXECUTIVE OFFICER | $339,576 | 20,034 | −1% | No | |
|
|
||||||
| Aug. 24, 2026 filed Aug. 20, 2026 | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER | $137,498 | 8,112 | −2% | No | |
|
|
||||||
| Aug. 24, 2026 filed Aug. 20, 2026 | Miller Aine SVP, DEV & HEAD OF IRE OFFICE | $106,073 | 6,258 | −3% | No | |
|
|
||||||
| Aug. 24, 2026 filed Aug. 20, 2026 | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | $134,786 | 7,952 | −2% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free